EUVIMEDEUVIMED entdecken
Crossref

HER-2 SMASH

Celal Alandağ, Ayşegül Öztürk, Fatih Yulak, Zeynep Deniz Şahin İnan, Mustafa Özkaraca, Burak Batuhan Lacın, Ahmet Altun

Cancer Chemotherapy and Pharmacology · 2025-12 · 95 (1)

DOI: 10.1007/s00280-024-04726-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Chemotherapy and Pharmacology, online erschienen am 23.12.2024. Verfasst von Celal Alandağ und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Sivas Medicana Hospital, Sivas, Türkiye. dralandag@hotmail.com. Hauptthemen laut MEDLINE: Erb-b2 Receptor Tyrosine Kinases, Lapatinib, Trastuzumab. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Erb-b2 Receptor Tyrosine KinasesLapatinibTrastuzumabHumansHT29 CellsMCF-7 CellsBreast NeoplasmsCell SurvivalUp-RegulationAdo-Trastuzumab EmtansineFemaleColonic NeoplasmsAntineoplastic AgentsQuinazolinesAntineoplastic Agents, ImmunologicalMaytansine

Stichwörter der Autor:innen

Her-2 overexpressionLapatinibSmash methodTrastuzumab

Substanzen

Erb-b2 Receptor Tyrosine KinasesLapatinibTrastuzumabAdo-Trastuzumab EmtansineAntineoplastic AgentsQuinazolinesAntineoplastic Agents, ImmunologicalMaytansineERBB2 protein, human

Autor:innen und Institutionen

  • Department of Medical Oncology, Sivas Medicana Hospital, Sivas, Türkiye. dralandag@hotmail.com.
  • Departments of Therapy and Rehabilitation, Vocational School of Health Services, Sivas Cumhuriyet University, Sivas, Türkiye.
  • Departments of Physiology, Medicine Faculty, Sivas Cumhuriyet University, Sivas, Türkiye.
  • Departments of Histology and Embryology, Medicine Faculty, Sivas Cumhuriyet University, Sivas, Türkiye.
  • Department of Pathology, School of Veterinary Medicine, Sivas Cumhuriyet University, 581140, Sivas, Türkiye.
  • Department of Physiology, Faculty of Veterinary Medicine, Ataturk University, 25240, Erzurum, Türkiye.

Zitieren

APA

Alandağ, C., Öztürk, A., Yulak, F., Şahin İnan, Z. D., Özkaraca, M., Lacın, B. B., & Altun, A. (2025). HER-2 SMASH. Cancer Chemotherapy and Pharmacology, 95(1). https://doi.org/10.1007/s00280-024-04726-9

Vancouver

Alandağ C, Öztürk A, Yulak F, Şahin İnan ZD, Özkaraca M, Lacın BB, et al. HER-2 SMASH. Cancer Chemotherapy and Pharmacology. 2025;95(1). doi:10.1007/s00280-024-04726-9

BibTeX
@article{Alanda2025,
  author = {Alandağ, Celal and Öztürk, Ayşegül and Yulak, Fatih and Şahin İnan, Zeynep Deniz and Özkaraca, Mustafa and Lacın, Burak Batuhan and Altun, Ahmet},
  title = {HER-2 SMASH},
  journal = {Cancer Chemotherapy and Pharmacology},
  year = {2025},
  volume = {95},
  number = {1},
  doi = {10.1007/s00280-024-04726-9}
}
Kostenlos starten →